BiopharmaStudySampleChecker

Biopharma Study Sample

Liquid Biopsy жидкостная биопсия cfDNA ctDNA CTC exosomes NGS qPCR
Open selection

Utility description: Biopharma Study Sample

Biopharma Study Sample Checker — Biopharma Study Sample Integrity Control

ℹ️  Utility performs comprehensive verification of preclinical and clinical study samples against protocol and GLP/GCP standards:
     • Informed Consent: Mandatory verification of signed IC for each clinical sample.
     • Temperature Integrity: Control of storage and transportation condition compliance.
     • Chain of Custody: Verification of continuous documentation trail for sample accountability.
     • Protocol Deviations: Recording and classification of any collection/storage procedure violations.

⚠️  IMPORTANT: 
     • Use of samples without confirmed consent is a gross violation of GCP and ethical standards.
     • Temperature breach may render sample unsuitable for PK/PD or ADA analysis.

Usage:
  BiopharmaStudySampleChecker.exe                            → demo mode (console output)
  BiopharmaStudySampleChecker.exe input.csv output.json      → evaluate your data

Input format:
StudyID,SubjectID,SampleID,MatrixType,Timepoint,CollectionDate,ReceiptDate,StorageTemp_C,MinStorageTemp_C,MaxStorageTemp_C,ConsentVerified,ChainOfCustodyComplete,ProtocolDeviation

Example:
  STUDY-001,SUBJ-01,SMP-001,Serum,Pre-dose,2026-06-01 08:00,2026-06-01 14:00,-70,-80,-60,true,true,

📍 Scope of Application (Usage Where):
     • Clinical Trials (Phase I-III): Sample receipt at central laboratory.
     • Preclinical Studies (GLP): Toxicokinetics and TK/PD sample control.
     • Biobanking: Inventory and quality check of stored samples.
     • Audits and Inspections: Confirmation of sample collection practice compliance with protocol.

— WHY IS THIS NEEDED?
Study data quality directly depends on sample quality.
Pre-analytical errors (mislabeling, temperature breach, missing consent) cannot be corrected retrospectively.
Automated verification prevents use of compromised samples and protects overall study integrity.

⚠️  CRITICAL:
• Consent: Missing verification = automatic REJECT.
• Temperature: Even few degrees deviation may denature protein therapeutics.
• CoC: Broken chain of custody questions sample origin.
• Deviations: All deviations must be documented and assessed by PI/Sponsor.

Key features:
• Multi-level verification (Consent → Temp → CoC → Deviation)
• Automatic status classification (Accepted/Quarantine/Rejected)
• Support for various matrix types and timepoints
• Report generation for auditors and sponsors
• Compliance with ICH E6(R2) and GLP requirements

Critical parameters:
• Consent Verified: True
• Storage Temp: Within established range
• Chain of Custody: Complete
• Protocol Deviation: None or documented

💡 Usage tips:
1. EDC Integration: Synchronize IC data from electronic data capture system.
2. Temperature Loggers: Use digital loggers for objective condition confirmation.
3. Staff Training: Regularly train coordinators on collection and labeling rules.
4. Documentation: Save all reports as part of Trial Master File.
5. Escalation: Immediately report IC violations to ethics committee.

⚠️ Note: This utility is a pre-analytical quality control tool. It does not replace clinical trial monitoring but ensures reliability of input data for laboratory analysis.

input.csv

StudyID,SubjectID,SampleID,MatrixType,Timepoint,CollectionDate,ReceiptDate,StorageTemp_C,MinStorageTemp_C,MaxStorageTemp_C,ConsentVerified,ChainOfCustodyComplete,ProtocolDeviation
STUDY-PH1-2026-001,SUBJ-001,SMP-001-PRE,Serum,Pre-dose,2026-06-01 08:00:00,2026-06-01 14:00:00,-70,-80,-60,true,true,
STUDY-PH1-2026-001,SUBJ-002,SMP-002-1H,Plasma,1h Post-dose,2026-06-02 09:00:00,2026-06-03 10:00:00,-45,-80,-60,true,false,Temperature excursion during transport
STUDY-PH1-2026-001,SUBJ-003,SMP-003-24H,Serum,24h Post-dose,2026-06-03 08:00:00,2026-06-03 12:00:00,-75,-80,-60,false,true,Consent pending verification

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of BiopharmaStudySampleChecker for Biopharma Study Sample Checker.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ⚠️ CRITICAL:
  • • Deviations: All deviations must be documented and assessed by PI/Sponsor.
  • • Compliance with ICH E6(R2) and GLP requirements
  • Critical parameters:

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file for Biopharma Study Sample Checker with headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.HighIdentical input data, rule version and configuration produce reproducible results.
URS-003The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.HighSchema, conversion and range errors are explicitly reported.
URS-004The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.HighEach check has PASS/WARNING/FAIL and a clear message.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall preserve traceability between batch/sample, input file, applied rules and final status.HighOutput contains identifiers, checked parameters and audit metadata.
URS-007The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.MediumURS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.MediumDocumentation states change control and limit-verification expectations.

input.csv contract

#FieldTypeSamplePurpose
1StudyIDstring / controlled vocabularySTUDY-PH1-2026-001Controlled input parameter for deterministic QC rules.
2SubjectIDstring / controlled vocabularySUBJ-001Controlled input parameter for deterministic QC rules.
3SampleIDstring / controlled vocabularySMP-001-PRESample or laboratory specimen identifier.
4MatrixTypestring / controlled vocabularySerumControlled input parameter for deterministic QC rules.
5Timepointstring / controlled vocabularyPre-doseTime parameter for process, incubation, storage or analytical workflow.
6CollectionDatestring / controlled vocabulary2026-06-01 08:00:00Controlled input parameter for deterministic QC rules.
7ReceiptDatestring / controlled vocabulary2026-06-01 14:00:00Controlled input parameter for deterministic QC rules.
8StorageTemp_Cdecimal-70Temperature profile/MKT; storage, shipping and stability parameter.
9MinStorageTemp_Cdecimal-80Temperature profile/MKT; storage, shipping and stability parameter.
10MaxStorageTemp_Cdecimal-60Temperature profile/MKT; storage, shipping and stability parameter.
11ConsentVerifiedstring / controlled vocabularytrueControlled input parameter for deterministic QC rules.
12ChainOfCustodyCompletestring / controlled vocabularytrueControlled input parameter for deterministic QC rules.
13ProtocolDeviationstring / controlled vocabularyControlled input parameter for deterministic QC rules.
StudyID,SubjectID,SampleID,MatrixType,Timepoint,CollectionDate,ReceiptDate,StorageTemp_C,MinStorageTemp_C,MaxStorageTemp_C,ConsentVerified,ChainOfCustodyComplete,ProtocolDeviation
STUDY-PH1-2026-001,SUBJ-001,SMP-001-PRE,Serum,Pre-dose,2026-06-01 08:00:00,2026-06-01 14:00:00,-70,-80,-60,true,true,
STUDY-PH1-2026-001,SUBJ-002,SMP-002-1H,Plasma,1h Post-dose,2026-06-02 09:00:00,2026-06-03 10:00:00,-45,-80,-60,true,false,Temperature excursion during transport
STUDY-PH1-2026-001,SUBJ-003,SMP-003-24H,Serum,24h Post-dose,2026-06-03 08:00:00,2026-06-03 12:00:00,-75,-80,-60,false,true,Consent pending verification

Input validation rules

IDFieldRuleCriticality
VR-001StudyIDThe field shall match an approved dictionary or accepted string representation.High
VR-002SubjectIDThe field shall match an approved dictionary or accepted string representation.High
VR-003SampleIDThe field shall match an approved dictionary or accepted string representation.High
VR-004MatrixTypeThe field shall match an approved dictionary or accepted string representation.Medium
VR-005TimepointThe field shall match an approved dictionary or accepted string representation.Medium
VR-006CollectionDateThe field shall match an approved dictionary or accepted string representation.Medium
VR-007ReceiptDateThe field shall match an approved dictionary or accepted string representation.Medium
VR-008StorageTemp_CThe field shall match an approved dictionary or accepted string representation.Medium
VR-009MinStorageTemp_CThe field shall match an approved dictionary or accepted string representation.Medium
VR-010MaxStorageTemp_CThe field shall match an approved dictionary or accepted string representation.Medium
VR-011ConsentVerifiedThe field shall match an approved dictionary or accepted string representation.Medium
VR-012ChainOfCustodyCompleteThe field shall match an approved dictionary or accepted string representation.Medium
VR-013ProtocolDeviationThe field shall match an approved dictionary or accepted string representation.Medium

FS — Functional Specification

IDFunctionImplementation
FS-001CLI executionSupport execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002CSV importRead input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003Schema validationCheck mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004Type conversionConvert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005Domain rule engineApply rules for Biopharma Study Sample Checker, including critical limits from the description and approved specification.
FS-006Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008Audit supportKeep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009Integration contractSupport the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010Error handlingReturn explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "biopharmastudysamplechecker",
  "utilityFolder": "BiopharmaStudySampleChecker",
  "package": "LiquidBiopsy",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "StudyID",
      "value": "STUDY-PH1-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "SubjectID",
      "value": "SUBJ-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "SampleID",
      "value": "SMP-001-PRE",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "MatrixType",
      "value": "Serum",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "Timepoint",
      "value": "Pre-dose",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "CollectionDate",
      "value": "2026-06-01 08:00:00",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "ReceiptDate",
      "value": "2026-06-01 14:00:00",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "StorageTemp_C",
      "value": "-70",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    },
    {
      "parameter": "MinStorageTemp_C",
      "value": "-80",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-009"
    },
    {
      "parameter": "MaxStorageTemp_C",
      "value": "-60",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-010"
    },
    {
      "parameter": "ConsentVerified",
      "value": "true",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-011"
    },
    {
      "parameter": "ChainOfCustodyComplete",
      "value": "true",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-012"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "BiopharmaStudySampleChecker.documentation.html"
  }
}

Traceability matrix

URSFSTestEvidence
URS-001FS-001, FS-002OQ-001Verify execution and import of valid input.csv.
URS-002FS-005, FS-006OQ-004Repeat the same dataset and compare output.json.
URS-003FS-003, FS-004, FS-010OQ-002, OQ-003Verify missing columns and invalid types.
URS-004FS-005, FS-006OQ-004, PQ-001Verify critical deviations on real/boundary data.
URS-005FS-007, FS-009OQ-005Verify JSON schema and downstream-system suitability.
URS-006FS-008OQ-006Verify identifiers and audit metadata.
URS-007FS-008, FS-010IQ-001, OQ-007Verify documentation completeness and control evidence.
URS-008FS-005, FS-008PQ-002Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

IDScenarioExpected result
IQ-001Verify executable, input.csv, documentation and checksum availability.Delivery set is complete; version is recorded.
OQ-001Valid sample row from input.csv.PASS or acceptable WARNING according to rules.
OQ-002Remove a mandatory CSV column.Schema error or FAIL with missing-column reference.
OQ-003Place a non-numeric value into a numeric field.Type-conversion error with row/field reference.
OQ-004Set a critical parameter outside the limit.FAIL and critical finding.
OQ-005Verify output.json structure.All mandatory sections are present and JSON is valid.
OQ-006Verify batch/sample traceability.Input and result identifiers match.
PQ-001Verify 3–5 real user batches/samples.Result is confirmed by QC/QA review.
PQ-002Verify deviation workflow and manual QA decision.Utility supports review but does not replace approved decision.

QA/QC and change control

  • Do not rename columns without updating validator, documentation and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
  • The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Liquid Biopsy QC Suite

QC and pre-analytical control package for liquid biopsy workflows: cfDNA/ctDNA, CTC, EV/exosomes, methylation, NGS/qPCR/ddPCR, sample quality, contamination, sensitivity and reporting checks.

Open